QTTB
Q32 Bio Inc.
NASDAQ · USHealthcareBiotechnology
$15.04-0.07%
Price as of Jul 20, 2026
QTTB valuation
Q32 Bio Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- 5.61x
- PEG TTM
- —
- Price / book
- 5.51x
- Price / sales
- 4.75x
- Price / cash flow
- -9.31x
Enterprise value
- Enterprise value
- $217.9M
- EV / sales
- 4.06x
- EV / EBITDA
- 9.84x
- EV / EBIT
- 10.18x
- Market cap
- $255.0M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.